Lack of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis

Pennington JE Wolff SM Puzies M . Summary of a workshop on infections in patients with cystic fibrosis. J Infect Dis 1979; 140: 252–6.

Greenberger NJ Toskes PP Isselbacher KJ . Diseases of the pancreas. In: Isselbacher KJ Adam RD Braumwald E eds. Harrison's principles of internal medicine. 9th ed. New York: McGraw-Hill, 1980: 1502–14.

DiSant'Agnese PA . Cystic fibrosis. In: Vaughn VC McKay RJ Behrman RE , eds. Nelson textbook of pediatrics. 11th ed. Philadelphia: W.B. Saunders, 1979: 1988–2001.

Matthews LW Dearborn DG Tucker AS . Cystic fibrosis. In: Fishman AP , ed. Pulmonary diseases and disorders. New York: McGraw-Hill, 1980: 600–13.

Greenberger NJ Winship DH . Gastrointestinal disorders: a pathophysiologic approach. Chicago: Year Book Medical Publishers, 1976: 250.

Hilman BC . Respiratory complications: The chief danger in CF. J Respr Dis 1981; 2: 75–89.

Vogelstein B Kowarski AA Lietman PS . The pharmacokinetics of amikacin in children. J Pediatr 1977; 91: 333–9.

Finkelstein E Hall K . Aminoglycoside clearance in patients with cystic fibrosis. J Pediatr 1979; 94: 163–4.

Hendeles L Stillwell P Mangos J Gentamicin dosage requirements for cystic fibrosis (abstract). Drug Intell Clin Pharm 1981; 15: 479.

Yaffe SJ Gerbracht LM Mosovich LL Pharmacokinetics of methicillin in patients with cystic fibrosis. J Infect Dis 1977; 135: 828–31.

Jusko WJ Mosovich LL Gerbracht LM Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 1975; 56: 1038–44.

Thomsen J Riis B . High dose tobramycin treatment of children with cystic fibrosis: Bacteriological effect and clinical ototoxicity. Int J Ped Otorhinolaryngol 1979; 1: 33–40.

Michalsen H Bergan T . Pharmacokinetics of netilmicin in children with and without cystic fibrosis. Antimicrob Agents Chemother 1981; 19: 1029–31.

Bauer LA Piecoro JJ Wilson D Blouin RA . Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis. Clin Pharm 1983; 2: 262–4.